🇺🇸 FDA
Company

EUPRAXIA

EUPRAXIA PHARMACEUTICALS INC.

EPRX pharma USA

Quick answer

EUPRAXIA is a pharma company (EPRX) headquartered in VICTORIA, A1, USA with 3 tracked pipeline programs.

Pipeline (3)

project

EP-104GI

Eosinophilic Esophagitis

Phase 2 · small_molecule · active

1 trials project

EP-104IAR 25 mg

Osteoarthritis, Knee

Phase 2 · small_molecule · completed

1 trials project

EP-104IAR

Osteoarthritis, Knee

Phase 1 · small_molecule · completed

1 trials

Patents (3)

patent

US 11351124

Sustained release of formulations of local anesthetics

Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11219604

Injectable sustained release composition and method of using the same for treati

Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9987233

Injectable sustained release composition and method of using the same for treati

Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)